Liposome Encapsulation Enhances the Antidiabetic Efficacy of Silibinin

Silibinin has considerable therapeutic potential for the treatment of diabetes through anti-inflammatory, antioxidant, and immunomodulatory properties. However, the therapeutic application of silibinin is quite limited due to its poor bioavailability. In the present study, an attempt was made to imp...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Svetlana Dinić (VerfasserIn), Jelena Arambašić Jovanović (VerfasserIn), Aleksandra Uskoković (VerfasserIn), Aleksandra Jovanović (VerfasserIn), Nevena Grdović (VerfasserIn), Jovana Rajić (VerfasserIn), Marija Đorđević (VerfasserIn), Ana Sarić (VerfasserIn), Branko Bugarski (VerfasserIn), Melita Vidaković (VerfasserIn), Mirjana Mihailović (VerfasserIn)
Format: Buch
Veröffentlicht: MDPI AG, 2024-06-01T00:00:00Z.
Schlagworte:
Online-Zugang:Connect to this object online.
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_e342955d391e435287f94e4738d95d89
042 |a dc 
100 1 0 |a Svetlana Dinić  |e author 
700 1 0 |a Jelena Arambašić Jovanović  |e author 
700 1 0 |a Aleksandra Uskoković  |e author 
700 1 0 |a Aleksandra Jovanović  |e author 
700 1 0 |a Nevena Grdović  |e author 
700 1 0 |a Jovana Rajić  |e author 
700 1 0 |a Marija Đorđević  |e author 
700 1 0 |a Ana Sarić  |e author 
700 1 0 |a Branko Bugarski  |e author 
700 1 0 |a Melita Vidaković  |e author 
700 1 0 |a Mirjana Mihailović  |e author 
245 0 0 |a Liposome Encapsulation Enhances the Antidiabetic Efficacy of Silibinin 
260 |b MDPI AG,   |c 2024-06-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics16060801 
500 |a 1999-4923 
520 |a Silibinin has considerable therapeutic potential for the treatment of diabetes through anti-inflammatory, antioxidant, and immunomodulatory properties. However, the therapeutic application of silibinin is quite limited due to its poor bioavailability. In the present study, an attempt was made to improve the antidiabetic efficacy of silibinin by its encapsulation in liposomal vesicles. The liposomes with a high encapsulation efficiency of silibinin (96%) and a zeta potential of −26.2 ± 0.6 mV were developed and studied using nicotinamide/streptozotocin-induced diabetic rats. Administration of silibinin-loaded liposomes to diabetic rats lowered glucose levels, increased insulin levels, and improved pancreatic islet architecture. The anti-inflammatory effect of silibinin-loaded liposomes was demonstrated by a decrease in serum C-reactive protein (CRP) levels and a reduced deposition of collagen fibers in the islets of diabetic rats. Furthermore, silibinin-loaded liposomes were more efficient in lowering glucose, alanine transaminase, triglyceride, and creatinine levels in diabetic rats than pure silibinin. In addition, silibinin-loaded liposomes had a significantly better effect on beta-cell mass and Glut2 glucose receptor distribution in diabetic islets than pure silibinin. The present results clearly show that liposome encapsulation of silibinin enhances its antidiabetic efficacy, which may contribute to the therapeutic benefit of silibinin in the treatment of diabetes and its complications. 
546 |a EN 
690 |a diabetes 
690 |a insulin 
690 |a silibinin 
690 |a liposomes 
690 |a antidiabetic 
690 |a anti-inflammatory 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 16, Iss 6, p 801 (2024) 
787 0 |n https://www.mdpi.com/1999-4923/16/6/801 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/e342955d391e435287f94e4738d95d89  |z Connect to this object online.